Ute Richarz

1.3k total citations
49 papers, 1.0k citations indexed

About

Ute Richarz is a scholar working on Anesthesiology and Pain Medicine, Physiology and Cognitive Neuroscience. According to data from OpenAlex, Ute Richarz has authored 49 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Anesthesiology and Pain Medicine, 25 papers in Physiology and 15 papers in Cognitive Neuroscience. Recurrent topics in Ute Richarz's work include Pain Management and Opioid Use (26 papers), Pain Mechanisms and Treatments (25 papers) and Pain Management and Placebo Effect (14 papers). Ute Richarz is often cited by papers focused on Pain Management and Opioid Use (26 papers), Pain Mechanisms and Treatments (25 papers) and Pain Management and Placebo Effect (14 papers). Ute Richarz collaborates with scholars based in Switzerland, United States and Germany. Ute Richarz's co-authors include Karen H Simpson, L. Allan, R. Slappendel, Jacques Devulder, Rolf Pokorny, Adam Jacobs, J Vojtaššák, A. J. Clark, Martin Koltzenburg and S. Ratcliffe and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pain and Spine.

In The Last Decade

Ute Richarz

48 papers receiving 954 citations

Peers

Ute Richarz
Clara C. Faura Spain
Shung-Tai Ho Taiwan
Eric Prommer United States
Jeffrey Fudin United States
Ashraf Yassen Netherlands
Thomas P. Enggaard Denmark
Craig Kornick United States
Andrew Moore United Kingdom
Salvatore V. Colucci United States
H. Quiding Sweden
Clara C. Faura Spain
Ute Richarz
Citations per year, relative to Ute Richarz Ute Richarz (= 1×) peers Clara C. Faura

Countries citing papers authored by Ute Richarz

Since Specialization
Citations

This map shows the geographic impact of Ute Richarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Richarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Richarz more than expected).

Fields of papers citing papers by Ute Richarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute Richarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Richarz. The network helps show where Ute Richarz may publish in the future.

Co-authorship network of co-authors of Ute Richarz

This figure shows the co-authorship network connecting the top 25 collaborators of Ute Richarz. A scholar is included among the top collaborators of Ute Richarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Richarz. Ute Richarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Benson, Carmela, Dean Najarian, Steven Wang, et al.. (2023). The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. Neuropsychiatric Disease and Treatment. Volume 19. 531–545. 20 indexed citations
3.
Conover, Mitchell M., James Weaver, G Leitz, et al.. (2023). Cardiovascular outcomes among patients with castration‐resistant prostate cancer: A comparative safety study using US administrative claims data. The Prostate. 83(7). 729–739. 9 indexed citations
4.
Najarian, Dean, et al.. (2023). Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia. The International Journal of Neuropsychopharmacology. 26(8). 537–544. 9 indexed citations
5.
6.
He, Jianming, Rian Van Rampelbergh, Lugui Qiu, et al.. (2020). Treatment Pattern and Outcomes in Newly Diagnosed Multiple Myeloma Patients Who Did Not Receive Autologous Stem Cell Transplantation: A Real-World Observational Study. Advances in Therapy. 38(1). 640–659. 8 indexed citations
7.
Fife, Daniel, John Waller, Sigal Kaplan, et al.. (2019). Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe. Clinical Drug Investigation. 39(11). 1057–1066. 4 indexed citations
8.
Devarakonda, Krishna, Joris Vandenbossche, & Ute Richarz. (2013). Complementary pharmacokinetic measures to further define the profile of once-daily OROS hydromorphone ER during single-dose and steady-state dosing. SpringerPlus. 2(1). 625–625. 4 indexed citations
9.
10.
Moore, Kenneth Todd, et al.. (2011). Steady-state pharmacokinetics of extended-release hydromorphone (OROS® hydromorphone): A randomized study in healthy volunteers. Journal of Opioid Management. 6(5). 351–358. 14 indexed citations
11.
Moore, Kenneth Todd, Gayatri Sathyan, Ute Richarz, Jaya Natarajan, & Joris Vandenbossche. (2011). Randomized 5‐Treatment Crossover Study to Assess the Effects of External Heat on Serum Fentanyl Concentrations During Treatment With Transdermal Fentanyl Systems. The Journal of Clinical Pharmacology. 52(8). 1174–1185. 23 indexed citations
12.
13.
Lussier, David, Ute Richarz, & Gabriele Finco. (2010). Use of Hydromorphone, with Particular Reference to the OROS® Formulation, in the Elderly. Drugs & Aging. 27(4). 327–335. 11 indexed citations
14.
Devulder, Jacques, et al.. (2009). Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. British Journal of Anaesthesia. 103(4). 576–585. 25 indexed citations
15.
Turgeon, Jacques, R Gröning, Gayatri Sathyan, John Thipphawong, & Ute Richarz. (2009). The pharmacokinetics of a long-acting OROS hydromorphone formulation. Expert Opinion on Drug Delivery. 7(1). 137–144. 15 indexed citations
16.
Kalso, Eija, Karen H Simpson, R. Slappendel, Joachim Dejonckheere, & Ute Richarz. (2007). Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine. BMC Medicine. 5(1). 39–39. 34 indexed citations
17.
Koltzenburg, Martin, Rolf Pokorny, Urs Gasser, & Ute Richarz. (2006). Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine. Pain. 126(1). 165–174. 61 indexed citations
18.
Langford, R. M., Frank McKenna, S. Ratcliffe, J Vojtaššák, & Ute Richarz. (2006). Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: A randomized, placebo‐controlled trial. Arthritis & Rheumatism. 54(6). 1829–1837. 76 indexed citations
19.
Loët, Xavier Le, Karel Pavelká, & Ute Richarz. (2005). Transdermal fentanyl for the treatment of pain caused by osteoarthritis of the knee or hip: an open, multicentre study. BMC Musculoskeletal Disorders. 6(1). 31–31. 18 indexed citations
20.
Allan, L., Ute Richarz, Karen H Simpson, & R. Slappendel. (2005). Transdermal Fentanyl Versus Sustained Release Oral Morphine in Strong-Opioid Naïve Patients With Chronic Low Back Pain. Spine. 30(22). 2484–2490. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clara C. Faura Breakdown of academic impact, for papers by Shung-Tai Ho Breakdown of academic impact, for papers by Eric Prommer Breakdown of academic impact, for papers by Jeffrey Fudin Breakdown of academic impact, for papers by Ashraf Yassen Breakdown of academic impact, for papers by Thomas P. Enggaard Breakdown of academic impact, for papers by Craig Kornick Breakdown of academic impact, for papers by Andrew Moore Breakdown of academic impact, for papers by Salvatore V. Colucci Breakdown of academic impact, for papers by H. Quiding
Rankless by CCL
2026